A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension
NCT02061683
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
263
Enrollment
INDUSTRY
Sponsor class
Conditions
Glaucoma, Open-Angle
Ocular Hypertension
Interventions
DRUG:
Bimatoprost 0.03%
Sponsor
Allergan